CD274 and neoplasm: In fact, we have demonstrated a significant increase in PD-L1-positive immune cells in surgical resections after gemcitabine therapy compared to the original tumor biopsy, although we cannot confirm that this specific to gemcitabine as the historical standard-of-care patients control group were not tested for PD-L1 expression.